A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to a new study conducted by researchers from the U.K., U.S. and Norway. This is the first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients...
Source: http://www.medicalnewstoday.com/releases/244938.php
Stirling Moss Jack Brabham Jacques Villeneuve Gerhard Berger
Tidak ada komentar:
Posting Komentar